Data / Form D filings / Dravite Therapeutics, Inc.
Dravite Therapeutics, Inc.: Form D filings
Dravite Therapeutics, Inc., a company in San Francisco, CA, filed 3 Form D notices with the SEC in 2026. The latest, on September 3, 2026, reports $53 million sold of a $53 million offering to 11 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 401 CAMBRIDGE STREET, San Francisco, CA, 94134
- Phone
- (510) 920-4145
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2133272
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | New notice | $52,999,992 | $52,999,992 | 11 | Aug 21, 2026 | sec.gov | |
| Jul 28, 2026 | Amendment | $14,983,333 | $14,983,333 | 8 | Apr 20, 2026 | sec.gov | |
| Jun 24, 2026 | New notice | $14,983,333 | $14,983,333 | 8 | Apr 20, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| JOSEPH SUM | Executive Officer, Director | |
| SANDEEP KULKARNI | Director | |
| BARBARA KOSACZ | Director | |
| MATTHEW MOORE | Executive Officer, Director | |
| JEREMY GOLDBERG | Director | |
| RISHI GUPTA | Director |
Other companies in California that filed recently
- MoFlo Acquisitions, Inc. $587.5 million · Nov 2, 2026
- BC Movie, LLC offering · Nov 2, 2026
- Jana Education San Jose LLC $200,000 · Nov 2, 2026
- Crosscut SPV Frontier LP - Series 2 $23.4 million · Oct 30, 2026
- Series 23-1, a series of StartEngine Private Funds LLC $314,025 · Oct 30, 2026
- Omnissa Holdco LLC offering · Oct 30, 2026
Every Form D from the week of Aug 31, 2026 · All recent filings in California · All recent Other filings
Read from SEC EDGAR. Amount sold is what Dravite Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.